BMRN vs OGS · P/E 40, rev $2.85B vs P/E 17, rev $2.58B
Biomarin Pharmaceutical Inc (BMRN) versus One Gas Inc (OGS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
One Gas Inc (OGS) is a utilities - regulated gas company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported OGS revenue for 2022-12-31 was $2.58B. Net income was $221.7M. OGS currently screens at market cap $4.85B and trailing P/E 17.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. OGS currently screens at market cap $4.85B and trailing P/E 17.4.
Not investment advice. Open the BMRN and OGS stock pages for the full models.
Not investment advice.